{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:03:18Z","timestamp":1790337798493,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372887"],"award-info":[{"award-number":["82372887"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.mtbio.2026.103533","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:26:33Z","timestamp":1785885993000},"page":"103533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["131I-labeled engineered hybrid cell membrane biomimetic nanocarrier targets gastric cancer and enhances radioimmunotherapy"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6554-9182","authenticated-orcid":false,"given":"Chuanqiang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8503-4071","authenticated-orcid":false,"given":"Anqi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mtbio.2026.103533_bib1","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-024-01654-2","article-title":"Helicobacter pylori and gastric cancer: mechanisms and new perspectives","volume":"18","author":"Duan","year":"2025","journal-title":"J. Hematol. Oncol."},{"issue":"10251","key":"10.1016\/j.mtbio.2026.103533_bib2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.mtbio.2026.103533_bib3","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/gutjnl-2019-320234","article-title":"Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035","volume":"69","author":"Arnold","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.mtbio.2026.103533_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2025.1592977","article-title":"The impact of Helicobacter pylori infection and eradication therapies on gut microbiota: a systematic review of microbial dysbiosis and its implications in gastric carcinogenesis","volume":"15","author":"Albush","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.mtbio.2026.103533_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2025.103038","article-title":"Precision oncology in gastric cancer: shaping the future of personalized treatment","volume":"141","author":"Migliore","year":"2025","journal-title":"Cancer Treat Rev."},{"issue":"7","key":"10.1016\/j.mtbio.2026.103533_bib6","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.trecan.2024.03.008","article-title":"Gastric cancer immunosuppressive microenvironment heterogeneity: implications for therapy development","volume":"10","author":"Yasuda","year":"2024","journal-title":"Trends Cancer"},{"key":"10.1016\/j.mtbio.2026.103533_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1291117","article-title":"Research progress on the immune microenvironment and immunotherapy in gastric cancer","volume":"14","author":"Mou","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103533_bib8","article-title":"Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103533_bib9","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/gutjnl-2024-333617","article-title":"CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases","volume":"74","author":"Li","year":"2025","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.mtbio.2026.103533_bib10","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2967\/jnumed.120.259192","article-title":"Feasibility, biodistribution, and preliminary dosimetry in peptide-targeted radionuclide therapy of diverse adenocarcinomas using 177Lu-FAP-2286: first-In-humans results","volume":"63","author":"Baum","year":"2022","journal-title":"J. Nucl. Med."},{"issue":"8","key":"10.1016\/j.mtbio.2026.103533_bib11","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1007\/s00259-023-06174-8","article-title":"Radionuclide-based theranostics \u2014 a promising strategy for lung cancer","volume":"50","author":"Zhu","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"9","key":"10.1016\/j.mtbio.2026.103533_bib12","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.7150\/ijbs.84797","article-title":"METTL3 regulates thyroid cancer differentiation and chemosensitivity by modulating PAX8","volume":"20","author":"Kang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103533_bib13","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1016\/S1470-2045(24)00656-9","article-title":"Proceedings of the national cancer institute workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translation","volume":"26","author":"Morris","year":"2025","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mtbio.2026.103533_bib14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jconrel.2024.10.010","article-title":"Biomaterials to regulate tumor extracellular matrix in immunotherapy","volume":"376","author":"Zhang","year":"2024","journal-title":"J. Contr. Release"},{"issue":"22","key":"10.1016\/j.mtbio.2026.103533_bib15","doi-asserted-by":"crossref","first-page":"6316","DOI":"10.1039\/D5BM01156F","article-title":"An activatable self-amplifying ROS nanoplatform for augmented cerenkov radiation-induced photodynamic therapy","volume":"13","author":"Xiong","year":"2025","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.mtbio.2026.103533_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adk0642","article-title":"Intratumoral radiation dose heterogeneity augments antitumor immunity in mice and primes responses to checkpoint blockade","author":"Jagodinsky","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103533_bib17","doi-asserted-by":"crossref","DOI":"10.1667\/RADE-21-00032.1","article-title":"Tolerance of normal rabbit facial bones and teeth to synchrotron X-Ray microbeam irradiation","volume":"197","author":"Laissue","year":"2021","journal-title":"Radiat. Res."},{"issue":"5","key":"10.1016\/j.mtbio.2026.103533_bib18","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.ijrobp.2019.08.027","article-title":"Synchrotron microbeam radiation therapy as a new approach for the treatment of radioresistant melanoma: potential underlying mechanisms","volume":"105","author":"Potez","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"10.1016\/j.mtbio.2026.103533_bib19","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.ijrobp.2021.07.1717","article-title":"Synchrotron microbeam radiation therapy for the treatment of lung carcinoma: a preclinical study","volume":"111","author":"Trappetti","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.mtbio.2026.103533_bib20","first-page":"1","article-title":"Harnessing bacterial membrane components for tumor vaccines: strategies and perspectives","author":"Bai","year":"2024","journal-title":"Adv. Healthcare Mater."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103533_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-40280-3","article-title":"Cancer cell-mitochondria hybrid membrane coated gboxin loaded nanomedicines for glioblastoma treatment","volume":"14","author":"Zou","year":"2023","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.mtbio.2026.103533_bib22","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41579-023-00875-5","article-title":"Composition and functions of bacterial membrane vesicles","volume":"21","author":"Toyofuku","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"issue":"8","key":"10.1016\/j.mtbio.2026.103533_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12357","article-title":"Mass\u2010produced gram\u2010negative bacterial outer membrane vesicles activate cancer antigen\u2010specific stem\u2010like CD8+ T cells which enables an effective combination immunotherapy with anti\u2010PD\u20101","volume":"12","author":"Won","year":"2023","journal-title":"J. Extracell. Vesicles"},{"issue":"42","key":"10.1016\/j.mtbio.2026.103533_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202405304","article-title":"Surface engineering on bacteria for tumor immunotherapy: strategies and perspectives","volume":"34","author":"Fu","year":"2024","journal-title":"Adv. Funct. Mater."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103533_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202404184","article-title":"Hybrid cell membrane\u2010coated nanoparticles for synergizing sonodynamic therapy and immunotherapy against triple\u2010negative breast cancer","volume":"14","author":"Gong","year":"2024","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.mtbio.2026.103533_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2020.05.028","article-title":"Hybrid cell membrane-coated nanoparticles: a multifunctional biomimetic platform for cancer diagnosis and therapy","volume":"112","author":"Chen","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.mtbio.2026.103533_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121297","article-title":"Biomimetic nanoparticles: U937 cell membranes based core\u2013shell nanosystems for targeted atherosclerosis therapy","volume":"611","author":"Shen","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"29","key":"10.1016\/j.mtbio.2026.103533_bib28","doi-asserted-by":"crossref","first-page":"26296","DOI":"10.1021\/acsnano.5c04463","article-title":"Tissue-resident macrophage membrane-coated nanomedicine for targeted tumor therapy","volume":"19","author":"Su","year":"2025","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.mtbio.2026.103533_bib29","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/s41423-024-01216-z","article-title":"Macrophage diversity in cancer dissemination and metastasis","volume":"21","author":"Mantovani","year":"2024","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103533_bib30","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s43018-025-00909-2","article-title":"Linking macrophage metabolism to function in the tumor microenvironment","volume":"6","author":"Jin","year":"2025","journal-title":"Nat. Cancer"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103533_bib31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1158\/2326-6066.CIR-20-0527","article-title":"The prognostic role of macrophage polarization in the colorectal cancer microenvironment","volume":"9","author":"V\u00e4yrynen","year":"2021","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103533_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-11788-4","article-title":"Macrophage spatial heterogeneity in gastric cancer defined by multiplex immunohistochemistry","volume":"10","author":"Huang","year":"2019","journal-title":"Nat. Commun."},{"issue":"19","key":"10.1016\/j.mtbio.2026.103533_bib33","doi-asserted-by":"crossref","first-page":"21848","DOI":"10.1021\/acsami.2c00211","article-title":"131I-Labeled silk fibroin microspheres for radioembolic therapy of rat hepatocellular carcinoma","volume":"14","author":"Wu","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"24","key":"10.1016\/j.mtbio.2026.103533_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ma16247550","article-title":"Organic and biogenic nanocarriers as bio-friendly systems for bioactive compounds' delivery: state-of-the art and challenges","volume":"16","author":"Petrovic","year":"2023","journal-title":"Materials"},{"issue":"12","key":"10.1016\/j.mtbio.2026.103533_bib35","doi-asserted-by":"crossref","first-page":"9114","DOI":"10.1021\/acsnano.4c00081","article-title":"Radionuclide-labeled antisilencing function 1a inhibitory peptides for tumor identification and individualized therapy","volume":"18","author":"Shi","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2026.103533_bib36","first-page":"1","article-title":"Reengineering the tumor oxygen microenvironment in radiotherapy to enhance t\u2010cell function for radio\u2010immunotherapy","author":"Chen","year":"2025","journal-title":"Adv. Funct. Mater."},{"issue":"18","key":"10.1016\/j.mtbio.2026.103533_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202207608","article-title":"Metabolic intervention liposome boosted lung cancer radio\u2010immunotherapy via hypoxia amelioration and PD\u2010L1 restraint","volume":"10","author":"Wang","year":"2023","journal-title":"Adv. Sci."},{"issue":"7571","key":"10.1016\/j.mtbio.2026.103533_bib38","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature15373","article-title":"Nanoparticle biointerfacing by platelet membrane cloaking","volume":"526","author":"Hu","year":"2015","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.mtbio.2026.103533_bib39","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.2217\/nnm-2019-0140","article-title":"Biocompatibility in regenerative nanomedicine","volume":"14","author":"Zor","year":"2019","journal-title":"Nanomedicine (Lond.)"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103533_bib40","first-page":"9","article-title":"Acute and subacute toxicity assessment of madhulai manappagu (siddha herbal syrup formulation) in animal model","volume":"19","author":"Malayappan","year":"2022","journal-title":"J. Compl. Integr. Med."},{"key":"10.1016\/j.mtbio.2026.103533_bib41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-1-0716-4108-8_10","article-title":"Transcriptomics in the study of antiviral innate immunity","author":"Zheng","year":"2025","journal-title":"Antiviral Innate Immunity"},{"key":"10.1016\/j.mtbio.2026.103533_bib42","doi-asserted-by":"crossref","first-page":"11181","DOI":"10.2147\/IJN.S483815","article-title":"Photo-thermally controllable tumor metabolic modulation to assist T cell activation for boosting immunotherapy","volume":"19","author":"Ma","year":"2024","journal-title":"Int. J. Nanomed."},{"issue":"11","key":"10.1016\/j.mtbio.2026.103533_bib43","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s41571-025-01069-z","article-title":"The molecular blueprint of targeted radionuclide therapy","volume":"22","author":"Primac","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.mtbio.2026.103533_bib44","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2967\/jnumed.125.271098","article-title":"Efficacy of CLDN18.2-targeted radiotheranostics in patient-derived models of gastric cancer","volume":"67","author":"Klauser","year":"2026","journal-title":"J. Nucl. Med."},{"issue":"12","key":"10.1016\/j.mtbio.2026.103533_bib45","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1007\/s00259-025-07293-0","article-title":"Efficacy of combined targeted radionuclide therapy and immune checkpoint inhibition in animal tumour models: a systematic review and meta-analysis of the literature","volume":"52","author":"Kleinendorst","year":"2025","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"17","key":"10.1016\/j.mtbio.2026.103533_bib46","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1158\/1078-0432.CCR-21-4332","article-title":"Combining targeted radionuclide therapy and immune checkpoint inhibition for cancer treatment","volume":"28","author":"Kleinendorst","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103533_bib47","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2967\/jnumed.117.194555","article-title":"Pharmacokinetics, biodistribution, and radiation dosimetry for ^89Zr-trastuzumab in patients with esophagogastric cancer","volume":"59","author":"O'Donoghue","year":"2018","journal-title":"J. Nucl. Med."}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426007787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426007787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:31:19Z","timestamp":1790335879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006426007787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":47,"alternative-id":["S2590006426007787"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103533","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"131I-labeled engineered hybrid cell membrane biomimetic nanocarrier targets gastric cancer and enhances radioimmunotherapy","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103533","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103533"}}